Related Experiment Videos
Phase II trial of PCNU in non-small cell lung cancer
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Identifying the genomic landscape of EGFR-mutant lung cancers with central nervous system metastases.
Annals of oncology : official journal of the European Society for Medical Oncology·2025
Deciphering radiological stable disease to immune checkpoint inhibitors.
Annals of oncology : official journal of the European Society for Medical Oncology·2022
COVID-19 in patients with lung cancer.
Annals of oncology : official journal of the European Society for Medical Oncology·2020
Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib.
Annals of oncology : official journal of the European Society for Medical Oncology·2019
PD-L1 expression, tumor mutational burden, and response to immunotherapy in patients with MET exon 14 altered lung cancers.
Annals of oncology : official journal of the European Society for Medical Oncology·2018
Cisplatin as a first-line treatment in T2 and T3 bladder carcinoma.
Cancer treatment reports·1987
IV melphalan in children.
Cancer treatment reports·1987
Interactions of methotrexate and cyclophosphamide with the pharmacokinetics of 5-fluorouracil in an animal model.
Cancer treatment reports·1987
Phase II trial of rDNA alfa 2b interferon in patients with malignant carcinoid tumor.
Cancer treatment reports·1987
Doxorubicin distribution in human breast cancer.
Cancer treatment reports·1987
Phase I study of echinomycin.
Cancer treatment reports·1987
Research Advances in Nanodrugs Targeting Lipid Metabolism Reprogramming for Colorectal Cancer Therapy.
International journal of nanomedicine·2026
Sleep-Disordered Breathing and Nocturnal Hypoxia in Cancer Patients: A Stomatological and Airway Assessment Framework.
Nature and science of sleep·2026
Robotic Resection With Hyperthermic Intrathoracic Perfusion Chemotherapy for Thymoma Recurrence.
Case reports in oncological medicine·2026